chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Flu like symptoms; Whole-body aches; Fatigue; Warm pressure sensation; leg pain, waist, back and glute region; Very Sleepy; Vomits; Headache; Nausea; Heart palpitations; swollen tongue; Numb tongue; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), PALPITATIONS (Heart palpitations), SWOLLEN TONGUE (swollen tongue), HYPOAESTHESIA ORAL (Numb tongue) and SOMNOLENCE (Very Sleepy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced PALPITATIONS (Heart palpitations), SWOLLEN TONGUE (swollen tongue), HYPOAESTHESIA ORAL (Numb tongue), NAUSEA (Nausea) and HEADACHE (Headache). On 09-Apr-2021, the patient experienced SOMNOLENCE (Very Sleepy) and VOMITING (Vomits). On 12-Apr-2021, the patient experienced FEELING HOT (Warm pressure sensation) and MYALGIA (leg pain, waist, back and glute region). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), MYALGIA (Whole-body aches) and FATIGUE (Fatigue). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), PALPITATIONS (Heart palpitations), SWOLLEN TONGUE (swollen tongue), HYPOAESTHESIA ORAL (Numb tongue), SOMNOLENCE (Very Sleepy), FEELING HOT (Warm pressure sensation), MYALGIA (leg pain, waist, back and glute region), FATIGUE (Fatigue) and VOMITING (Vomits) had resolved and MYALGIA (Whole-body aches), NAUSEA (Nausea) and HEADACHE (Headache) had not resolved. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided. No treatment information provided.
Patient had pneumovax 9 am on 8/28/09, began feeling achy by 1 pm, warm in evening.  By the morning of 8/29 his temperature was 101, going to 102.4 max.  He also developed a slight cough, wheeze with spasmodic cough, along with a loss of appetite.  He was seen on 8/31 when he was already feeling better.  However, upon examination there was the suspicion of pneumonia, so he was started on bronchodilators (albuterol) and azithromycin, and he was sent for a chest x-ray.  Tonight he reports he is feeling less achy although he still has a slight cough. He states his fever was gone by 9/2 in pm.
History of fever of 104 within 4-5 hours post vax. Remained elevated for 4-5 hours and returned to normal.
Weakness and fatique,painful joints of left knee and hip and right hip severe, generalized mucular aches and pain .  brain fog, canot concentrate.
generalized hives and rash all over her body that started 12/2/21. stabilized after taking benadryl x2.
Havrix, adult hepatitis A, was administered as the second dose in a hepatitis A series to a pediatric patient.
Did not sleep well after shots.  Crying off and on during evening.  Call if symptoms worse.
A report has been received from a Physician concerning a 1 year old, female subject, who had been receiving Nasal FLUMIST QUADRIVALENT (Intranasal). Concomitant medications included Antiemetics and Antinauseants and Oseltamivir. FLUMIST QUADRIVALENT (Intranasal) started on an unknown date. The patient experienced fever and vomiting which started on 18-Sep-2013. The outcome of the event of fever is unknown and the patient recovered from the event of vomiting on an unspecified date. The report was considered to be non-serious. The reporter considered the causal relationship between the suspect drug FLUMIST QUADRIVALENT and the event fever and vomiting to be related.
Tested positive for COVID-19. Initially went to see healthcare provider regarding an interesting rash on hands (small bumps/blisters) that started on 2021-12-20. Evening of 2021-12-21, developed a very small sore throat (ticklish). Tested positive with a rapid COVID-19 test. Developed a worsening cough and congestion over the next few days. Cough has persisted until 2021-01-02.  Lots of fluids, including warm water with honey and lemon. Used over-the-counter cough medicine the last few days. Cough has slightly lessened on 2021-01-03. As a result of constant coughing, ribs seem to be bruised and coughing can be painful.
arm was very sore; hard to lift; felt very unwell; lightheaded; very cold; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was very sore), MOVEMENT DISORDER (hard to lift), MALAISE (felt very unwell), DIZZINESS (lightheaded) and NASOPHARYNGITIS (very cold) in a 61-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 016M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm was very sore), MOVEMENT DISORDER (hard to lift), MALAISE (felt very unwell), DIZZINESS (lightheaded) and NASOPHARYNGITIS (very cold). At the time of the report, PAIN IN EXTREMITY (arm was very sore), MOVEMENT DISORDER (hard to lift), MALAISE (felt very unwell), DIZZINESS (lightheaded) and NASOPHARYNGITIS (very cold) outcome was unknown.            No concomitant medications were reported.  Treatment medications included Ibuprofen Motrin 200 mg.  Action taken with mRNA-1273 in response to the events was not applicable.
No adverse affect noted, patient and family were waiting in the observation area for the recommended time, Parents were recommended to give daughter Motrin or Tylenol later on this evening and to call for questions and emergency room if any adverse affects were observed. Parents verbalized understanding of after care education.
Rash, probable erythema multiforme from Smallpox reaction.  10/27/08 ER record dated 9/5/08 received with DX:  Rash, probable Erythema Muliforme small pox vaccination reaction. Pt presented with 2 day hx of rash.  Red, raised multi-shaped rash noted on torso, extremities and addomen. Tx with steroids and d/c on Medrol dosepak.
severe back pain after receiving COVID vaccine.  Patient reports was walking out after receiving her booster and had intense sharp pain in her lower and mid back. Had never experienced this after a vaccine previously. Patient also reported has some anxiety and this was triggered by the back pain.
Pt. was given vaccines (FLUCELVAX and PNEUMOVAX) on his left Deltoid 03/11/19, was seen by a provider the following day, 03/12/19  for fever and was prescribed doxycycline tablet, hyclate 100 mg, 1 tab(s), orally, 2 times a day x 10 days. Pt. returned 03/14/19 to see PCP, c/o left arm swelling and burning , fever, shaking, unable to move arms every bone in by body started hurting, bone aches,  chills. Diagnosis of left arm cellulitis, allergy to antibiotics. Prescribed tramadol tablet, 50 mg, 1 tab(s), orally, every 8 hours, 3 days. Scheduled a f/u with a provider on 03/25/19.
Received vaccine on 10-17-21 no issues on 10-18-21 Redness, mild pain, slightly warm near injection site 10-19-21 Pt thought size had increased slightly on 10-20-21 Seeked medical attention on 10-21-21, doctor diagnosed as cellulitis, pt reported location of rash had moved more towards underarm and thought was slightly less red, no change in pain level
Patient received her first Pfizer vaccine today at 12:24pm .She was sent to observation  feeling well. About 10 to15 minutes later she began to complain to her son that her head felt "bloated", her eyes felt heavy and her head felt hot. The nurse removed the patient to the nurses station and took her vital signs, then notified the clinical lead PN. The patient Initial vital signs taken at 13:15 were BP 157/85 P 78 , O2 sat  99%,. R 18. Denies Shortness of breath, difficulty breathing or swallowing. No skin color changes noted. No rash or pruritis. Denies chest pain, pressure or palpitations. Consumed a bottle of water without difficulty. About 20 minutes after the vaccine was received she began to feel faint, but did not feel as though she was "going to pass out" . VS remained stable;  BP 157/85/P78.O2sat 99%   She continued to c/o head fullness, but now was  reporting feeling chills, and flushing . Son administered an extra strength Tylenol at 13:10. Nurse acted as interpreter as well as her son. Paramedics were called initially at 12:56 and again at 13:21  Patient was able to get up and walk to the bathroom  with attendants , voided  under observation and return to her chair without complaints of instability or dizziness.  Paramedics arrived at 13:45. Vs were noted to be 160/90  , pulse 75, O2sat 99% Patient continued to complain of head and eye fullness  and vertigo( Paramedic looked like her was swaying). Patient appeared stable ,in no acute distress when she was escorted out of the building ambulance  by paramedics  at 13:55 to be taken to a Hospital for evaluation.
This is in follow-up to report(s) previously submitted on 8/14/2007: Initial and follow up information has been received from a physician and a medical assistant, via a company representative, concerning a 12 year old female patient, with no known allergies or medical conditions, who on 13-JUL-2007, at 10:05am, was vaccinated IM in the right deltoid, with the first dose, 0.5ml, of GARDASIL (Lot #655619/1427F). Concomitant vaccine therapy included ADACEL (Lot #C2734AA), administered at 10:00am, IM in the left deltoid, and ENGERIX-B (Lot #AHBVB289CA), administered at 10:03am, IM in the left vastus lateralis. On 13-JUL-2007, at 10:07am, the patient experienced nausea and passed out. She was helped to lie down, had a cool cloth applied to her forehead, was assessed by the physician, and then given soda to help with the nausea. She was observed for a total of 20 minutes. The patient recovered from the events on the same day, 13-JUL-2007. The patient sought unspecified medical attention. No further information is expected.
This is a spontaneous report from a contactable Nurse. This nurse reported similar events for 2 patients. This is 1st of 2 reports. An 11-12 year-old patient (child) patient of an unspecified ethnicity and gender received TRUMENBA via an unspecified route of administration at single dose into the thigh muscle on an unspecified date for immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date the patient was administered TRUMENBA into the thigh muscle instead of the deltoid because the patient had less muscle mass, and experienced a larger local reactions compared to the older children given TRUMENBA in the deltoid with outcome of unknown. Sender's Comments: Linked Report(s): US-PFIZER INC-2017266663 same reporter, different patient, same drug/events.
Information has been received from two health professionals the authors of a literature article concerning a 12 month old male who was vaccinated with MMR (lot number not reported). The patient's mother was vaccinated with a dose of MMR in the immediate post-partum period and it was reported that the baby was breast-fed beyond 18 months of age. In the first year of life, he was severely constipated and had three viral illnesses with generalized exanthems. he was immunized on the recommended schedule and received his first MMR  at the age of 12 months. Prior to this time, the boy had appropriate speech and above-average cognitive abilities, but he stopped progressing after his first birthday and then went on to lose previously acquired skills. A developmental evaluation done at a chronological age of 20 months revealed an approximate developmental age of 11-13 months (language, motor, and cognitive). Autistic symptoms are now apparent and a diagnosis of autism is forthcoming. The mother also developed severe arthritis of her knees, ankles, and hips following her own vaccination. Upon internal review, autistic symptoms were considered to be other important medical event (OMIC). No further information is expected.
Information has been received from a consumer concerning his 84 year old wife, with no known allergies who on 05-JUN-2007 was vaccinated in the left arm (also reported as left deltoid) with a 0.5 ml dose of Zostavax (Oka/Merck) (lot # 657559/0462U).  Concomitant therapy included aspirin 81 mg, HCTZ/triamterene, NORVASC, NEXIUM and vitamins (unspecified).  A week and a half after the vaccination, on approximately 15-JUN-2007, the patient developed blisters and pain on the right arm.  The patient visited her physician on 06-JUL-2007 and was diagnosed with shingles.  At the time of report the blisters were gone, but the pain still persisted.  No further information was provided.  There was no product quality complaint involved.  Additional information has been received from a medical assistant.  She confirmed that the patient was seen at the office on 06-JUL-2007 and diagnosed with shingles.  Patient was being treated with tapering doses of prednisone and LYRICA 75mg by mouth twice a day.  Medical assistant requested information about the VZVID program.  Additional information was received from a physician.  The patient has concurrent conditions of hypertension, increased cholesterol, coronary artery stenosis, glucose intolerance, and renal insufficiency.  The patient has a codeine allergy (previously reported as no known allergies).  The patient was vaccinated in the left deltoid on 05-JUN-2007 with a 0.5 ml dose of Zostavax (Oka/Merck) (lot#657559/0462U).  No rash occurred at the injection site post vaccination.  On 01-JUL-2007 (reported by the consumer as one and a half weeks after vaccination) the patient developed herpes zoster which was diagnosed on 06-JUL-2007.  The patient's rash was described as multiple vesicular herpetic lesions down the right arm.  The patient's maximum temperature was 99 degrees Fahrenheit (also reported as 98 degrees).  The patient's pain was rated as a six on a scale of zero to ten (zero equals least ten equals most).  The patient has no history of chicken pox and there was no recent exposure to chicken pox or herpes zoster.  A direct fluorescent antibody was not done, nor was a specimen collected for PCR.  On an unspecified date the patient recovered.  Additional information was received indicating that the patient was" trying to get recourse."  Additional information has been requested at this time.
Pt states arm was tender for a few days and now it is "itchy" (10/15/15). Raised red rash 2" x 4" about 2" below injection site noted. PCV13 given on 10/07/15 to left deltoid. States the rash area started at injection site but now has "moved down arm". Encouraged her to take an antihistamine and use hot or cool packs as needed.
Several minutes after Menactra was given pt felt dizzy and Tired. Pt was monitored for 1 hour and had juice.
Information has been received from a physician concerning a 16 year old female who on 08 Nove 2006 was vaccinated intramuscularly with the first dose of Gardasil (yeast) (Lot # not provided). On 09 Nov 2006 it was reported that the patient developed hives. Unspecified medical attention was sought. At the time of this report it was unknown if the patient had recovered. Additional information has been requested.
Migraine Headache At 12:30pm.  Fatigue at 2:30pm Temperature at 12:00am  Pain at injection site.
This spontaneous report was received from a physician refers to a 12 year old male patient. The patient had no pertinent medical history or drug reaction/allergies. There was no concomitant medication. On 07-AUG-2017, the patient was vaccinated with first dose of GARDASIL 9 (site: left arm, dose, strength, route, lot, expiry date unspecified) in 2 dose immunization series for prophylaxis. The patient's family sought medical attention and contacted physician's office since the patient experienced left arm injection site pain, redness, swelling and nausea in approximately August 2017. There was no real treatment given other than suggestion for ice to injection site and unspecified home remedies to reduce nausea. The outcome of the events and causality was unknown. Product quality complaint (PQC) was not involved. No further information was provided.
This spontaneous report was received from a Licensed Practical Nurse referring to an unspecified number of patients of unknown ages and genders. The patients' medical history or concurrent conditions were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of M-M-R II (which had the lot # L032182, expiration date 25-AUG-2017)(dose, route, strength and anatomical site of vaccination were not reported). Information regarding concomitant medication was not reported. Additionally, no adverse effects were reported. There was not a product quality complaint involved. This is one of several cases from the same reporter. Additional information has been requested.
Received an HPV vaccine on 7/18. That evening got a very sharp LUQ pain, felt like a poking sharp sensation. No other symptoms. Lasted for about 10 minutes. Then 3 days later, legs started to feel numb and tingling. Legs feeling like this and feel really tired with stair climbing or other exertion. Left arm and right hand intermittently tingly. The bump at the injection site is still present and then a week ago the entire right side of neck and tops of shoulder hurting. The size of the bump at injection site has enlarged. Started Rifampin July 10.
patient has not received the 2nd Dose > 35 days after the 1st Dose; Patient started experiencing fatigue; worsening nausea; worsening headache; worsening joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (patient has not received the 2nd Dose > 35 days after the 1st Dose), FATIGUE (Patient started experiencing fatigue), NAUSEA (worsening nausea), HEADACHE (worsening headache) and ARTHRALGIA (worsening joint pain) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in September 2020. Concurrent medical conditions included Autoimmune disorder and Blood pressure high (high blood pressure).    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced FATIGUE (Patient started experiencing fatigue), NAUSEA (worsening nausea), HEADACHE (worsening headache) and ARTHRALGIA (worsening joint pain). On 24-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (patient has not received the 2nd Dose > 35 days after the 1st Dose). On 24-Mar-2021, PRODUCT DOSE OMISSION ISSUE (patient has not received the 2nd Dose > 35 days after the 1st Dose) had resolved. At the time of the report, FATIGUE (Patient started experiencing fatigue), NAUSEA (worsening nausea), HEADACHE (worsening headache) and ARTHRALGIA (worsening joint pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Based on the current available information and temporal association between the use of the product and the start dates of the events of nausea, arthralgia, fatigue and headache, a causal relationship cannot be excluded. This report also refers to an event of dose omission.  There were no AEs specifically associated with this medication error  Concomitant medications included thyroid medications, high blood pressure medications.  Treatment medication was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Additional information received on 03-May-2021 received as email address was updated.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start dates of the events of nausea, arthralgia, fatigue and headache, a causal relationship cannot be excluded. This report also refers to an event of dose omission.  There were no AEs specifically associated with this medication error
Excessive twitching on left side of face . Under my eyes and left cheek for a long period of time. I also experience heart palpitation while this is happening.
screaming from 230Pm-630PM-some spitting-not taking pacifier or bottle;rt leg swollen;
pt had light-headedness p/inj;BP was checked & found to be elevated 160/100 (seated);primary provider was called to see if wanted to see pt BP checked 10min;later was 170/100 (seated);MD advised to call amb & send pt to ER for further eval;
I was bothered by the flu vaccine. I got COVID in December 11, 2022. I experienced sinus, ear infection, nasal drainage, some muscle aches and everything tasty salty. I got tested for COVID on 12-11-2022. I did not take anti-viral medications and slept with my head elevated. I did not have an appetite. I tested negative the day after Christmas.  My doctor put me on Doxycycline for one week and it took me awhile to get better since I also had GI symptoms. I also had some pleura in my lungs. I was losing half a pound of day. I dropped 30 pounds. I also have kidney cancer, stage 4, it is not genetic. Now I have been feeling bit better since mid March 2023.
Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. On or about 26-JUN-2014, the patient was vaccinated at a pharmacy with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 23-JAN-2016, the patient was treated at a hospital for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster. The patient was prescribed VALTREX, and PERCOCET for management of her painful and persistent symptoms. On or about 05-APR-2016, the patient sought subsequent treatment for ongoing and worsening symptoms, which was then diagnosed as herpes zoster dermatitis. The patient was prescribed VALTREX, and PERCOCET and LOTRISONE for management of her persistent and painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Information has been received from the patient's friend, referring to a patient of unknown gender and age. Information on medical history, concomitant medication and drug allergies was not provided. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (dose, route, lot# and expiration date unknown) for prevention of shingles. On an unknown date, the patient experienced pain and swelling after receiving the ZOSTAVAX injection. The outcome of the events was unknown. The causality assessment was not provided. Additional information is not expected as the reporter did not consent to be contacted.
Developed thrombocytopenia purpura approximately 5 weeks post vaxs. Presented on 08/02 with 2 week history of "rash."